|  b | SE (b) |  β | p-value |
---|---|---|---|---|
Age >80 | 13.92 | 4.47 | 0.229 | 0.002 |
BMI<20 | −4.07 | 2.89 | −0.106 | 0.161 |
Hospitalization for >2 days in the preceding 90 day; n (%) | 4.15 | 4.63 | 0.068 | 0.371 |
Residence in a nursing home or long-term care facility | 14.48 | 5.49 | 0.196 | 0.009 |
Home infusion therapy (including antibiotics) | 9.88 | 7.26 | 0.102 | 0.170 |
ECOG PS of premorbid condition>3 | 23.37 | 4.87 | 0.341 | <0.001 |
COPD | −0.28 | 5.60 | −0.004 | 0.960 |
Interstitial pneumonia | 0.18 | 7.92 | 0.002 | 0.982 |
Lung cancer | −0.16 | 9.55 | −0.001 | 0.987 |
Bronchiectasis | −6.63 | 7.28 | −0.069 | 0.364 |
Cerebrovascular disease | 7.75 | 5.85 | 0.100 | 0.187 |
Neuromuscular diseases | 8.62 | 7.09 | 0.092 | 0.226 |
Dementia | 8.14 | 6.20 | 0.099 | 0.191 |
Gastroesophageal disorder | 5.72 | 6.12 | 0.705 | 0.351 |
Pharyngeal disorder | 19.48 | 11.22 | 0.130 | 0.084 |
Presence of the risk factor for aspiration | 12.78 | 4.31 | 0.219 | 0.004 |
Malignancy excluding lung cancer | −1.73 | 5.10 | −0.026 | 0.735 |
Psychiatric disease | 1.68 | 12.18 | 0.010 | 0.891 |
Sleeping medications | 10.24 | 6.08 | 0.126 | 0.094 |
Antipsychotic drugs | −4.94 | 10.61 | −0.035 | 0.642 |
Antidepressant | 10.40 | 10.01 | 0.078 | 0.300 |
History of pneumonia within the previous 1Â year | 16.12 | 4.92 | 0.241 | 0.001 |
Albumin<4 g/dl | −3.25 | 6.56 | −0.037 | 0.621 |
Bilateral lung involvement | 0.01 | 4.37 | 0.0002 | 0.998 |
Lower lobe opacity | −4.67 | 4.40 | −0.08 | 0.291 |
Posterior dominant opacity | 4.56 | 4.87 | 0.071 | 0.351 |
Gravity-dependent opacity | −7.52 | 5.27 | −0.107 | 0.155 |